BioSpace News Archive

Endo International plc announced that members of management will participate in a fireside chat at the Bank of America Merrill Lynch Leveraged Finance Conference in Boca Raton, Florida on Tuesday, December 3, 2019 at 8:50 a.m. ET..

Hemostemix Inc. (“Hemostemix” or the “Company”) (TSX VENTURE: HEM; OTCQB: HMTXF), a biotechnology company focused on developing and commercializing innovative blood-derived stem cell therapies for medical conditions not adequately addressed by current treatments, announces the resignation of Mr. Don Friesen from the Company’s board of directors (“the “Board”) effective November 21, 2019.

Brooks Automation, Inc. announced that company management will participate in two upcoming investor conferences

MOBE is pleased to announce a relationship with Horizon Healthcare Services, Inc., New Jersey’s largest health insurer, to reduce claims costs and overall health care expenses by improving health outcomes.

Business-to-business publisher WTWH Media today announced that Ken Goldberg, William S. Floyd Distinguished Chair of Engineering, University of California, Berkeley, will deliver a keynote address at the 2019 Healthcare Robotics Engineering Forum.

Agios Pharmaceuticals, Inc. (NASDAQ:AGIO), a leader in the field of cellular metabolism to treat cancer and rare genetic diseases, today presented updated data from the ongoing perioperative study, confirming brain penetrance and robust biomarker suppression with treatment of single agent vorasidenib or TIBSOVO® (ivosidenib) in low-grade glioma with an IDH1 mutation

Baxter International Inc. (NYSE:BAX), a leading global medical products company, today announced that the New York Stock Exchange (NYSE) notified the Company that it is not in compliance with Section 802.01E of the NYSE Listed Company Manual due to a delay in filing its Quarterly Report on Form 10-Q for the quarter ended September 30, 2019 with the Securities and Exchange Commission (SEC).

BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, announced today that it will present at the Evercore ISI 2nd Annual HealthCONx Conference on Wednesday, December 4, 2019, at 11:45 a.m. ET.

Technavio has announced its latest market research report titled global in-vitro colorectal cancer screening tests market 2019-2023.

Hutchison China MediTech Limited will share analyses from two clinical studies of savolitinib and fruquintinib at the fifth European Society for Medical Oncology Asia Congress on November 22 to 24, 2019 in Singapore.